isobutyramide has been researched along with Urinary Bladder Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, S; Hara, I; Hara, S; Kamidono, S; Miyake, H | 1 |
1 other study(ies) available for isobutyramide and Urinary Bladder Neoplasms
Article | Year |
---|---|
Overexpression of Bcl-2 regulates sodium butyrate- and/or docetaxel-induced apoptosis in human bladder cancer cells both in vitro and in vivo.
Topics: Amides; Animals; Antineoplastic Agents; Apoptosis; Butyrates; Cell Division; Docetaxel; Female; Genes, bcl-2; Humans; Mice; Mice, Nude; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Taxoids; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2001 |